73 related articles for article (PubMed ID: 3428124)
1. Effects of doxorubicin on mouse heart catalase.
D'Alessandro N; Nicotra C; Crescimanno M; Rausa L
Drugs Exp Clin Res; 1987; 13(10):601-6. PubMed ID: 3428124
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiple doxorubicin doses on mouse cardiac and hepatic catalase.
D'Alessandro N; Candiloro V; Crescimanno M; Flandina C; Dusonchet L; Crosta L; Rausa L
Pharmacol Res Commun; 1984 Feb; 16(2):145-51. PubMed ID: 6504966
[TBL] [Abstract][Full Text] [Related]
3. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
Crescimanno M; Flandina C; Rausa L; Sanguedolce R; D'Alessandro N
Chemioterapia; 1988 Feb; 7(1):53-9. PubMed ID: 3163942
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of doxorubicin and isoproterenol on reduced glutathione and H2O2 production in mouse heart.
D'Alessandro N; Rausa L; Crescimanno M
Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):19-30. PubMed ID: 3205977
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.
Doroshow JH; Locker GY; Myers CE
J Clin Invest; 1980 Jan; 65(1):128-35. PubMed ID: 7350193
[TBL] [Abstract][Full Text] [Related]
6. [Effect of ethanol and the catalase inhibitor aminotriazole on the activity of antioxidative enzymes in the rat liver and heart].
Antonenkov VD; Gusev VA; Krasnova SN
Vopr Med Khim; 1987; 33(6):59-64. PubMed ID: 3445547
[TBL] [Abstract][Full Text] [Related]
7. Prevention by fructose-1,6-bisphosphate of cardiac oxidative damage induced in mice by subchronic doxorubicin treatment.
Lazzarino G; Viola AR; Mulieri L; Rotilio G; Mavelli I
Cancer Res; 1987 Dec; 47(24 Pt 1):6511-6. PubMed ID: 3677089
[TBL] [Abstract][Full Text] [Related]
8. The influence of doxorubicin and 4'-epi-doxorubicin on lipid peroxidation in mouse heart, lungs and liver. Part II.
Pierściński G; Drzewoski J; Nowak D
Pol J Pharmacol; 1994; 46(1-2):55-9. PubMed ID: 7981772
[TBL] [Abstract][Full Text] [Related]
9. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
[TBL] [Abstract][Full Text] [Related]
10. Vitamin A inhibits doxorubicin-induced membrane lipid peroxidation in rat tissues in vivo.
Ciaccio M; Valenza M; Tesoriere L; Bongiorno A; Albiero R; Livrea MA
Arch Biochem Biophys; 1993 Apr; 302(1):103-8. PubMed ID: 8470886
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs.
Lehotay DC; Levey BA; Levey GS
Biomed Pharmacother; 1983; 37(7):312-6. PubMed ID: 6141818
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
Naidu MU; Kumar KV; Mohan IK; Sundaram C; Singh S
Indian J Exp Biol; 2002 Aug; 40(8):894-900. PubMed ID: 12597018
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of malondialdehyde in mouse heart following acute dosing with adriamycin is strain specific and unaffected by cardiac catalase status.
Baird MB; Hough JL; Sfeir GT
Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):363-6. PubMed ID: 8351415
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
15. Evidence that catalase is a major pathway of ethanol oxidation in vivo: dose-response studies in deer mice using methanol as a selective substrate.
Bradford BU; Seed CB; Handler JA; Forman DT; Thurman RG
Arch Biochem Biophys; 1993 May; 303(1):172-6. PubMed ID: 8489262
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of muscle gene expression by oxidative stress in cardiac cells.
Torti SV; Akimoto H; Lin K; Billingham ME; Torti FM
J Mol Cell Cardiol; 1998 Jun; 30(6):1173-80. PubMed ID: 9689591
[TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
18. Acute adriamycin cardiotoxicity in rats.
Porta EA; Joun NS; Matsumura L; Nakasone B; Sablan H
Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):125-37. PubMed ID: 6622826
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
[TBL] [Abstract][Full Text] [Related]
20. Adaptive response of antioxidant enzymes to catalase inhibition by aminotriazole in goldfish liver and kidney.
Bagnyukova TV; Storey KB; Lushchak VI
Comp Biochem Physiol B Biochem Mol Biol; 2005 Nov; 142(3):335-41. PubMed ID: 16168691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
